.Merck defeats profits assumptions, raises purchases outlook on tough requirement for best medications like Keytruda CNBCMerck & Co. (MRK United States) Trumps Earnings Forecasts as Keytruda Sales Rise BloombergMerck Sell: Pharma Giant Posts Tough End Results, However Overview Drops Short Entrepreneur's Company DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck beats profit and purchases assumptions amid Keytruda strength, but delivers blended full-year outlook MarketWatch.